ABSTRACT
Objective: In patients receiving inappropriate empirical antimicrobial agents, delaying of time to report positive hemoculture (TRH) may cause delay switching from inappropriate antimicrobial agents to appropriate antimicrobial agents, and thus may increase mortality. We hypothesized that the patients with septicemia from different types of pathogens may have differ duration of TRH, and duration of TRH may had an impact on hospital mortality. Material and Method: We performed observational study on the patients who were reported to have bacteremia or fungemia and admitted to the surgical intensive care unit, Phramongkutklao Hospital during a 2-year period. Type of pathogens grew in blood cultures and the sensitivities to antimicrobial agents were collected from blood culture reports. Patients were categorized into three groups based on their blood culture reports which were gram-positive (GP) bacteria, gram-negative (GN) bacteria, and fungus. Primary outcome was duration of TRH and secondary outcome was hospital mortality among the three groups of patients. Results: There were 9, 32, and 7 patients for whom growth of GP bacteria (18.8%), GN bacteria (66.7%), and fungus (14.6%) were reported in their blood cultures respectively. Patients with fungemia had the longest TRH (130 hours, interquartile range (IQR) 100-137 hours), followed by patients with GN (64 hours, IQR 48-78 hours), and GP bacteremia (55 hours, IQR 42-71 hours) (p = 0.001). There was no difference in hospital mortality (GP 89%, GN 66%, fungus 71%, p = 0.4). TRH was found significantly longer in survivors (n = 14) (81 hours, IQR 56-105 hours) than non-survivors (n = 34) (64 hours, IQR 48-71 hours) (p = 0.035). In multivariate analysis, we found that every 1-hr increasing of TRH was associated with lower risk of hospital mortality with adjusted odd ratio of 0.95 (0.92-0.99, p = 0.01). Conclusion: Patients with fungemia had significantly longer TRH than patients with GP and GN bacteremia. TRH was found significantly longer in patients with septicemia who survived than non-survivors.
